NCT05058521

Brief Summary

Venous thromboembolism (VTE) is a complex multifactorial disease, mainly manifested by deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE events increase the length of hospitalization and treatment costs and seriously affect the quality of life of patients, so it is increasingly appreciated to identify high-risk patients with VTE and take preventive measures. The Padua prediction score (PPS) and Caprini risk assessment model (RAM) are widely used in clinical practice as common risk assessment scales in medical and surgical departments, respectively. And D-dimer levels have been considered as a well indicator to rule out acute VTE. Previous epidemiological studies on VTE have found the risk of VTE is significantly higher in hospitalized patients than in the general population and the prophylaxis decisions vary among countries, hospitals and departments, indicating current in-hospital VTE prevention strategies are far from optimal and it's imperative to regionalized control of VTE. Therefore, a single-institution-based risk profile study of in-hospital VTE patients is designed to explore current situation of VTE occurrence and predictive efficacy of widely used risk assessment models as well as D-dimer in one of the general hospitals in Beijing, China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27,490

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 6, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 27, 2021

Completed
Last Updated

September 27, 2021

Status Verified

September 1, 2021

Enrollment Period

1.9 years

First QC Date

September 6, 2021

Last Update Submit

September 23, 2021

Conditions

Keywords

VTEChinaCaprini risk assessment modelPadua prediction scoreRisk profiles

Outcome Measures

Primary Outcomes (4)

  • The rate of in-hospital VTE

    The diagnosis of VTE was confirmed as the occurrence of a critical value alert during hospitalization, which was predefined as ultrasound/radiology report of DVT or/and PE.

    From June 2018 to April 2020

  • Caprini risk assessment model scores

    Patients were stratified of VTE risk as very low risk (0), low risk (1-2), medium risk (3-4), high risk (5 and over).

    Through discharge, an average of 20 days

  • Padua prediction score scores

    Patients were stratified of VTE risk as low risk (0-3) and high risk (4 and over).

    Through discharge, an average of 20 days

  • D-dimer values

    The upper normal value 0.55mg/L FEU was used.

    Through discharge, an average of 20 days

Study Arms (2)

In-hospital VTE group

In-hospital VTE group includes patients who were with a hospital stay over 3 days and new-onset of VTE during their stay. Patients who presented for VTE were excluded.

Negative group

Negative group includes patients who were with a hospital stay over 3 days and did not have a VTE during their hospital stay.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The investigators recruited adult inpatients attending Tsinghua Chang Gung Hospital in Beijing from June 2018 to April 2020.

You may qualify if:

  • Age 18 and over, male or female
  • Inpatients with a hospital stay over 3 days
  • With or without new-onset of VTE during their stay

You may not qualify if:

  • Patients who presented for DVT and/or PE
  • Patients who were admitted in emergency department

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tsinghua Chang Gung Hosipital

Beijing, 102218, China

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Weiwei Wu, MD

    Beijing Tsinghua Chang Gung Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
23 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2021

First Posted

September 27, 2021

Study Start

June 1, 2018

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

September 27, 2021

Record last verified: 2021-09

Locations